W81XWH22C0030
Definitive Contract
Overview
Government Description
Follow-on phase III research and development SBIR for project titled, broad-spectrum snakebite antidote: oral product development and IV Clinical Study. Includes the Development Of an Oral Broad-Spectrum Snakebite Antidote and Conducting A Clinical Study for Intravenous (IV) administration.
Awardee
Awarding / Funding Agency
Place of Performance
Corte Madera, CA 94925 United States
Pricing
Fixed Price
Set Aside
Small Business Set Aside - Total (SBA)
Extent Competed
Full And Open Competition After Exclusion Of Sources
Research Type
Small Business Innovation Research Program (SBIR) Phase III
Est. Average FTE
30
Related Opportunity
75N91018R1PHS
Analysis Notes
Amendment Since initial award the Potential End Date has been extended from 07/20/24 to 12/04/25 and the Potential Award value has increased 70% from $13,827,499 to $23,443,944.
Ophirex was awarded
Definitive Contract W81XWH22C0030 (W81XWH-22-C-0030)
for SBIR for Broad-Spectrum Snakebite Antidote
worth up to $23,443,944
by Defense Health Agency
in April 2022.
The contract
has a duration of 3 years 8 months and
was awarded
with a Small Business Total set aside
with
NAICS 541715 and
PSC AN13
via direct negotiation acquisition procedures with 1 bid received.
DOD Announcements
Apr 2022:
Ophirex Inc.,* Corte Madera, California, was awarded a $13,827,499 hybrid (cost-plus-fixed-fee and firm-fixed-price) contract for broad-spectrum snakebite antidote oral product development and clinical study. Bids were solicited via the internet with one received. Work will be performed in Corte Madera, California, with an estimated completion date of Aug. 4, 2024. Fiscal 2021 research, development, test and evaluation, defense-wide funds in the amount of $13,827,499 were obligated at the time of the award. U.S. Army Medical Research Acquisition Activity, Fort Detrick, Maryland, is the contracting activity (W81XWH-22-C-0030).
Status
(Complete)
Last Modified 3/19/24
Period of Performance
4/5/22
Start Date
12/4/25
Current End Date
12/4/25
Potential End Date
Obligations
$23.4M
Total Obligated
$23.4M
Current Award
$23.4M
Potential Award
Award Hierarchy
Definitive Contract
W81XWH22C0030
Subcontracts
Activity Timeline
Transaction History
Modifications to W81XWH22C0030
People
Suggested agency contacts for W81XWH22C0030
Competition
Number of Bidders
1
Solicitation Procedures
Negotiated Proposal/Quote
Evaluated Preference
None
Performance Based Acquisition
Yes
Commercial Item Acquisition
Commercial Item Procedures Not Used
Simplified Procedures for Commercial Items
No
Other Categorizations
Subcontracting Plan
Plan Not Required
Cost Accounting Standards
Exempt
Business Size Determination
Small Business
Defense Program
None
DoD Claimant Code
Services
IT Commercial Item Category
Not Applicable
Awardee UEI
W452WY5E2JQ9
Awardee CAGE
7JTR0
Agency Detail
Awarding Office
HT9425 ARMY MED RES ACQ ACTIVITY
Funding Office
HT0986
Created By
micaela.l.bowers.civ.ht9425@health.mil
Last Modified By
micaela.l.bowers.civ.ht9425@health.mil
Approved By
micaela.l.bowers.civ.ht9425@health.mil
Legislative
Legislative Mandates
None Applicable
Performance District
CA-02
Senators
Dianne Feinstein
Alejandro Padilla
Alejandro Padilla
Representative
Jared Huffman
Budget Funding
| Federal Account | Budget Subfunction | Object Class | Total | Percentage |
|---|---|---|---|---|
| Defense Health Program, Defense (097-0130) | Department of Defense-Military | Research and development contracts (25.5) | $5,085,931 | 100% |
Modified: 3/19/24